Pegaptanib sodium
Modify Date: 2024-01-02 18:30:28
Pegaptanib sodium structure
|
Common Name | Pegaptanib sodium | ||
|---|---|---|---|---|
| CAS Number | 222716-86-1 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Pegaptanib sodiumPegaptanib sodium is an RNA aptamer directed against vascular endothelial growth factor (VEGF)-165. Pegaptanib could be used for the study of neovascular age-related macular degeneration (AMD) [1]. |
| Name | Pegaptanib sodium |
|---|
| Description | Pegaptanib sodium is an RNA aptamer directed against vascular endothelial growth factor (VEGF)-165. Pegaptanib could be used for the study of neovascular age-related macular degeneration (AMD) [1]. |
|---|---|
| Related Catalog | |
| In Vitro | Pegaptanib also inhibits VEGF165-mediated phosphorylation of VEGFR2 and phospholipase Cγ and inhibited VEGF165-induced calcium mobilization in human umbilical vein endothelial cells[1]. |
| References |
| No Any Chemical & Physical Properties |